DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$233.72
+1.57%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$235.33
From 52W high−3.44%
Volume1.20M
Market cap$164.43B
P/E (TTM)38.2x
P/S (TTM)6.4x
Div yield0.65%
Key dataNov 4, 2026
Open
$235.33
From 52W high
−3.44%
Volume
1.20M
Market cap
$164.43B
ValuationView details →
P/E (Fwd)
25.7x
EV/EBITDA
26.1x
P/E (TTM)
38.2x
RSI (14)
57.6
MomentumView details →
1D Return
+1.57%
YTD Return
+1.61%
SummaryUpdated Sep 1, 2026
Danaher Corporation (NYSE:DHR) is a diversified life sciences and diagnostics company founded in 1969 and headquartered in Washington, D.C. Originally established as Diversified Mortgage Investors, Inc., the company underwent a significant transformation and changed its name to Danaher Corporation in 1984. Over the decades, Danaher has evolved from a diversified industrial conglomerate into a focused life sciences powerhouse through strategic acquisitions and divestitures. The company went public in 1978 and has since built a portfolio of leading brands serving the biotechnology, life sciences research, and clinical diagnostics markets worldwide.
Similar companies
Latest newsMore news →
Genedata AG announced that it had added NVIDIA CORP’s RFD4-Proteina binder-design model to its AI-enabled production discovery workflows.13d agoDANAHER CORP /DE/ raised its adjusted earnings outlook for 2026.14d agoDANAHER CORP /DE/ reported quarterly earnings of $2.11 per share, above the Zacks Investment Research, Inc. consensus estimate of $1.92 and compared with $1.89 per share a year earlier.14d ago